Amanda Handcock shares the story of her dad’s brave fight with kidney cancer. Today, Amanda is an active advocate for other kidney cancer patients. Thank...Read More
In the Making a Difference series, KCCure’s Director of Patient Engagement, Laura Loughlin will be highlighting organizations making a difference in Kidne...Read More
AVEO Oncology announced today that the Phase 3 TIVO-3 Trial of Tivozanib in metastatic kidney cancer has met its primary endpoint.
Forgot your password?
No account? Sign up
Please enter your username or email address. You will receive a link to create a new password via email.
Already have an account? Login instead